LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma
Open Access
- 1 June 2012
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 21 (6), 751-764
- https://doi.org/10.1016/j.ccr.2012.03.048
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- Proinvasion Metastasis Drivers in Early-Stage Melanoma Are OncogenesCancer Cell, 2011
- A phase 2 trial of dasatinib in advanced melanomaCancer, 2010
- Somatic p16INK4a loss accelerates melanomagenesisOncogene, 2010
- Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung TumorsCancer Cell, 2010
- Activity of the multikinase inhibitor dasatinib against ovarian cancer cellsBritish Journal of Cancer, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell ProliferationMolecular Cell, 2009
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- LKB1 modulates lung cancer differentiation and metastasisNature, 2007